 | • レポートコード：GIR-105X17928 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、三価インフルエンザワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。三価インフルエンザワクチンの種類別市場規模（筋肉内注射、点鼻薬、皮内注射）、用途別市場規模（病院、クリニック、保健所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・三価インフルエンザワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi Pasteur、AstraZeneca、CSL、Abbott、GlaxoSmithKline、Serum Institute of India ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：筋肉内注射、点鼻薬、皮内注射 ・用途別分析2016年-2026年：病院、クリニック、保健所、その他 ・三価インフルエンザワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・三価インフルエンザワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・三価インフルエンザワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・三価インフルエンザワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・三価インフルエンザワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Trivalent Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Trivalent Flu Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Trivalent Flu Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Trivalent Flu Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intramuscular Injection
Nasal Spray
Intradermal Shot
Market segment by Application can be divided into
Hospital
Clinic
Public Health Agency
Other
The key market players for global Trivalent Flu Vaccine market are listed below:
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Serum Institute of India
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Trivalent Flu Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Trivalent Flu Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Market Analysis by Application
1.3.1 Overview: Global Trivalent Flu Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Public Health Agency
1.3.5 Other
1.4 Global Trivalent Flu Vaccine Market Size & Forecast
1.4.1 Global Trivalent Flu Vaccine Sales in Value (2016-2026))
1.4.2 Global Trivalent Flu Vaccine Sales in Volume (2016-2026)
1.4.3 Global Trivalent Flu Vaccine Price by Type (2016-2026) & (USD/Dose)
1.5 Global Trivalent Flu Vaccine Production Capacity Analysis
1.5.1 Global Trivalent Flu Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Trivalent Flu Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Trivalent Flu Vaccine Market Drivers
1.6.2 Trivalent Flu Vaccine Market Restraints
1.6.3 Trivalent Flu Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Trivalent Flu Vaccine Product and Services
2.1.4 Sanofi Pasteur Trivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Trivalent Flu Vaccine Product and Services
2.2.4 AstraZeneca Trivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Trivalent Flu Vaccine Product and Services
2.3.4 CSL Trivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Trivalent Flu Vaccine Product and Services
2.4.4 Abbott Trivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Trivalent Flu Vaccine Product and Services
2.5.4 GlaxoSmithKline Trivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Trivalent Flu Vaccine Product and Services
2.6.4 Serum Institute of India Trivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Trivalent Flu Vaccine Sales by Manufacturer
3.1 Global Trivalent Flu Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Trivalent Flu Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Trivalent Flu Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Trivalent Flu Vaccine Manufacturer Market Share
3.4.2 Top 6 Trivalent Flu Vaccine Manufacturer Market Share
3.5 Global Trivalent Flu Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Trivalent Flu Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Trivalent Flu Vaccine Market Size by Region
4.1.1 Global Trivalent Flu Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Trivalent Flu Vaccine Revenue by Region (2016-2026)
4.2 North America Trivalent Flu Vaccine Revenue (2016-2026)
4.3 Europe Trivalent Flu Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Trivalent Flu Vaccine Revenue (2016-2026)
4.5 South America Trivalent Flu Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Trivalent Flu Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Trivalent Flu Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Trivalent Flu Vaccine Revenue by Type (2016-2026)
5.3 Global Trivalent Flu Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Trivalent Flu Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Trivalent Flu Vaccine Revenue by Application (2016-2026)
6.3 Global Trivalent Flu Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Trivalent Flu Vaccine Sales by Type (2016-2026)
7.2 North America Trivalent Flu Vaccine Sales by Application (2016-2026)
7.3 North America Trivalent Flu Vaccine Market Size by Country
7.3.1 North America Trivalent Flu Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Trivalent Flu Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Trivalent Flu Vaccine Sales by Type (2016-2026)
8.2 Europe Trivalent Flu Vaccine Sales by Application (2016-2026)
8.3 Europe Trivalent Flu Vaccine Market Size by Country
8.3.1 Europe Trivalent Flu Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Trivalent Flu Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Trivalent Flu Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Trivalent Flu Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Trivalent Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Trivalent Flu Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Trivalent Flu Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Trivalent Flu Vaccine Sales by Type (2016-2026)
10.2 South America Trivalent Flu Vaccine Sales by Application (2016-2026)
10.3 South America Trivalent Flu Vaccine Market Size by Country
10.3.1 South America Trivalent Flu Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Trivalent Flu Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Trivalent Flu Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Trivalent Flu Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Trivalent Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Trivalent Flu Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Trivalent Flu Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Trivalent Flu Vaccine Typical Distributors
12.3 Trivalent Flu Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Trivalent Flu Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Trivalent Flu Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Trivalent Flu Vaccine Product and Services
Table 6. Sanofi Pasteur Trivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Trivalent Flu Vaccine Product and Services
Table 10. AstraZeneca Trivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Trivalent Flu Vaccine Product and Services
Table 14. CSL Trivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Trivalent Flu Vaccine Product and Services
Table 18. Abbott Trivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Trivalent Flu Vaccine Product and Services
Table 22. GlaxoSmithKline Trivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India Trivalent Flu Vaccine Product and Services
Table 26. Serum Institute of India Trivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Trivalent Flu Vaccine Sales by Manufacturer (2019-2021e) & (K Doses)
Table 28. Global Trivalent Flu Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Trivalent Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Trivalent Flu Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 31. Head Office and Trivalent Flu Vaccine Production Site of Key Manufacturer
Table 32. Global Trivalent Flu Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 33. Global Trivalent Flu Vaccine Sales by Region (2021-2026) & (K Doses)
Table 34. Global Trivalent Flu Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 35. Global Trivalent Flu Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 36. Global Trivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 37. Global Trivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 38. Global Trivalent Flu Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 39. Global Trivalent Flu Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 40. Global Trivalent Flu Vaccine Price by Type (2016-2021e) & (USD/Dose)
Table 41. Global Trivalent Flu Vaccine Price by Type (2021-2026) & (USD/Dose)
Table 42. Global Trivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 43. Global Trivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 44. Global Trivalent Flu Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 45. Global Trivalent Flu Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 46. Global Trivalent Flu Vaccine Price by Application (2016-2021e) & (USD/Dose)
Table 47. Global Trivalent Flu Vaccine Price by Application (2021-2026) & (USD/Dose)
Table 48. North America Trivalent Flu Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 49. North America Trivalent Flu Vaccine Sales by Country (2021-2026) & (K Doses)
Table 50. North America Trivalent Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 51. North America Trivalent Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 52. North America Trivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 53. North America Trivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 54. North America Trivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 55. North America Trivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 56. Europe Trivalent Flu Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 57. Europe Trivalent Flu Vaccine Sales by Country (2021-2026) & (K Doses)
Table 58. Europe Trivalent Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 59. Europe Trivalent Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 60. Europe Trivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 61. Europe Trivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 62. Europe Trivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 63. Europe Trivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 64. Asia-Pacific Trivalent Flu Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 65. Asia-Pacific Trivalent Flu Vaccine Sales by Region (2021-2026) & (K Doses)
Table 66. Asia-Pacific Trivalent Flu Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 67. Asia-Pacific Trivalent Flu Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 68. Asia-Pacific Trivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 69. Asia-Pacific Trivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 70. Asia-Pacific Trivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 71. Asia-Pacific Trivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 72. South America Trivalent Flu Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 73. South America Trivalent Flu Vaccine Sales by Country (2021-2026) & (K Doses)
Table 74. South America Trivalent Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 75. South America Trivalent Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 76. South America Trivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 77. South America Trivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 78. South America Trivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 79. South America Trivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 80. Middle East & Africa Trivalent Flu Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 81. Middle East & Africa Trivalent Flu Vaccine Sales by Country (2021-2026) & (K Doses)
Table 82. Middle East & Africa Trivalent Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 83. Middle East & Africa Trivalent Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa Trivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 85. Middle East & Africa Trivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 86. Middle East & Africa Trivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 87. Middle East & Africa Trivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Trivalent Flu Vaccine Typical Distributors
Table 91. Trivalent Flu Vaccine Typical Customers
List of Figures
Figure 1. Trivalent Flu Vaccine Picture
Figure 2. Global Trivalent Flu Vaccine Sales Market Share by Type in 2020
Figure 3. Intramuscular Injection
Figure 4. Nasal Spray
Figure 5. Intradermal Shot
Figure 6. Global Trivalent Flu Vaccine Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Public Health Agency
Figure 10. Other
Figure 11. Global Trivalent Flu Vaccine Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 12. Global Trivalent Flu Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Trivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Trivalent Flu Vaccine Sales (2016-2026) & (K Doses)
Figure 33. Global Trivalent Flu Vaccine Production Capacity (2016-2026) & (K Doses)
Figure 34. Global Trivalent Flu Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Trivalent Flu Vaccine Market Drivers
Figure 36. Trivalent Flu Vaccine Market Restraints
Figure 37. Trivalent Flu Vaccine Market Trends
Figure 38. Global Trivalent Flu Vaccine Sales Market Share by Manufacturer in 2020
Figure 39. Global Trivalent Flu Vaccine Revenue Market Share by Manufacturer in 2020
Figure 40. Trivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Trivalent Flu Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Trivalent Flu Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Trivalent Flu Vaccine Sales Market Share by Region (2016-2026)
Figure 44. Global Trivalent Flu Vaccine Revenue Market Share by Region (2016-2026)
Figure 45. North America Trivalent Flu Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. Europe Trivalent Flu Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Trivalent Flu Vaccine Revenue (2016-2026) & (USD Million)
Figure 48. South America Trivalent Flu Vaccine Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Trivalent Flu Vaccine Revenue (2016-2026) & (USD Million)
Figure 50. Global Trivalent Flu Vaccine Sales Market Share by Type (2016-2026)
Figure 51. Global Trivalent Flu Vaccine Revenue Market Share by Type (2016-2026)
Figure 52. Global Trivalent Flu Vaccine Price by Type (2016-2026) & (USD/Dose)
Figure 53. Global Trivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 54. Global Trivalent Flu Vaccine Revenue Market Share by Application (2016-2026)
Figure 55. Global Trivalent Flu Vaccine Price by Application (2016-2026) & (USD/Dose)
Figure 56. North America Trivalent Flu Vaccine Sales Market Share by Country (2016-2026)
Figure 57. North America Trivalent Flu Vaccine Revenue Market Share by Country (2016-2026)
Figure 58. North America Trivalent Flu Vaccine Sales Market Share by Type (2016-2026)
Figure 59. North America Trivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 60. Europe Trivalent Flu Vaccine Sales Market Share by Country (2016-2026)
Figure 61. Europe Trivalent Flu Vaccine Revenue Market Share by Country (2016-2026)
Figure 62. Europe Trivalent Flu Vaccine Sales Market Share by Type (2016-2026)
Figure 63. Europe Trivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Trivalent Flu Vaccine Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Trivalent Flu Vaccine Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Trivalent Flu Vaccine Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Trivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 68. South America Trivalent Flu Vaccine Sales Market Share by Country (2016-2026)
Figure 69. South America Trivalent Flu Vaccine Revenue Market Share by Country (2016-2026)
Figure 70. South America Trivalent Flu Vaccine Sales Market Share by Type (2016-2026)
Figure 71. South America Trivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Trivalent Flu Vaccine Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Trivalent Flu Vaccine Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Trivalent Flu Vaccine Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Trivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の4価インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別 The Quadrivalent Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 三価クロム仕上げの世界市場2018-2025 This study focuses on the production side and consumption side of Trivalent Chromium Finishing, presents the global Trivalent Chromium Finishing market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.In terms of production side, th…
- 世界の点鼻スプレー式インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別 The Nasal Spray Flu Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- クロストリジウムワクチン（動物の健康）の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Clostridium vaccines are used to provide immunity against for a variety of ovine and bovine clostridial diseases such as tetanus, black disease, pulpy kidney (enterotoxaemia), and blackleg. Scope of the Report: This report focuses on the Clostridium Vaccine (Animal Health) in global market, especial…
- 世界のワクチン輸送箱市場 2021：企業別、地域別、種類・用途別 The Vaccine Shipping Box market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…